CAZZAGON, NORA
CAZZAGON, NORA
Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS
2009 Ferrara, Francesco; Caroli, Diego; Antoniazzi, Sara; Variola, Angela; Cazzagon, N; Baldo, Vincenzo; Floreani, Annarosa
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS
2009 Ferrara, Francesco; Caroli, Diego; Antoniazzi, Sara; Variola, Angela; Cazzagon, N.; Baldo, Vincenzo; Floreani, Annarosa
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS
2010 Cazzagon, N; Chemello, Liliana; Martines, Diego; Cavalletto, L; Baldo, Vincenzo; Floreani, Annarosa
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS
2010 Cazzagon, N.; Chemello, Liliana; Martines, Diego; Cavalletto, L.; Baldo, Vincenzo; Lazzari, Roberta; Floreani, Annarosa
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload.
2011 Floreani, Annarosa; Navaglia, F; Rizzotto, Er; Basso, Daniela; Chiaramonte, M; Padoan, Andrea; Petridis, I; Cazzagon, N; Testa, R; Marra, M; Plebani, Mario
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre.
2011 Floreani, Annarosa; Caroli, D; Variola, A; Rizzotto, Er; Antoniazzi, S; Chiaramonte, M; Cazzagon, N; Brombin, C; Salmaso, Luigi; Baldo, Vincenzo
Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention.
2011 Giacomin, A; Cazzagon, N; Sergio, A; Vanin, V; Farinati, Fabio
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis.
2011 Floreani, Annarosa; Cazzagon, N; Martines, D; Cavalletto, L; Baldo, Vincenzo; Chemello, Liliana
Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response.
2011 Floreani, Annarosa; Cazzagon, N; Boemo, Dg; Baldovin, Tatjana; Baldo, Vincenzo; Egoue, J; Antoniazzi, S; Minola, E.
New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC
2011 Farinati, Fabio; Cazzagon, N; Giacomin, A.
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment.
2011 Floreani, Annarosa; Cazzagon, N; Furlan, P; Baldovin, Tatjana; Egoue, J; Antoniazzi, S; Baldo, Vincenzo; Minola, E.
P.1.158: PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE
2011 Cazzagon, N.; Boemo, DERIS GIANNI; Baldovin, T.; Baldo, V.; EGOUE MONGOUE, REMY JOEL; Antoniazzi, S.; Minola, E.; Floreani, A.
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from 20-year multicentre experience in Italy
2012 Farinati, Fabio; Giacomin, Anna; Vanin, Veronica; Sergio, A; Burra, Patrizia; Cillo, Umberto; Di Golfo, A; Del Poggio, P; Benvegnu', Luisa; Zoli, M; Borzio, F; Giannini, Eg; Caturelli, E; Cazzagon, Nora; Rapaccini, Gl; Trevisani, F; Alberti, Alfredo; Italian Liver Cancer, Group
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challenges.
2012 Giacomin, A; Sergio, A; Vanin, V; Gazzola, A; Cazzagon, N; Farinati, Fabio
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.
2013 Cazzagon, N; Trevigiani, F; Mandalo, G; Giacomin, A; Vanin V, Pozzan C; Poggio, Pd; Rapaccini, G; Nolfo, Am; Benvegnu', Luisa; Zoli M, Borzio F; Giannini, Eg; Caturelli, E; Chiaramonte, M; Foschi, Fg; Cabibbo, G; Felder, M; Ciccarese, F; Missale, G; Baroni, Gs; Morisco, F; Pecorelli, A; Farinati, Fabio; Alberti, Alfredo; Italian Liver Cancer, Group
Sleep-wake profiles in patients with primary biliary cirrhosis
2013 Montagnese, Sara; Nsemi, Lm; Cazzagon, N; Facchini, S; Costa, L; Bergasa, Nv; Amodio, Piero; Floreani, Annarosa
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study
2014 Lammers, W. J.; van BUUREN, H. R.; Hirschfield, G. M.; Janssen, H. L.; Invernizzi, P.; Mason, A. L.; Ponsioen, C. Y.; Floreani, Annarosa; Corpechot, C.; Mayo, M. Y.; Battezzati, P. M.; Pares, A.; Nevens, F.; Burroughs, A. K.; Kowdley, K. V.; Trivedi, P. J.; Kumagi, T.; Cheung, A.; Lleo, A.; Imam, M. H.; Boonstra, K.; Cazzagon, N.; Fraceschet, I.; Poupon, R.; Caballeria, L.; Pieri, G.; Kanwar, P. S.; Lindor, K. D.; Hansen, B. E.; GLOBAL PBC Study, Group
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC
2014 Franceschet, Irene; Motta, Raffaella; A., Mantovan; Cazzagon, Nora; Baldo, Vincenzo; Buja, Alessandra; Floreani, Annarosa
New therapies for primary biliary cirrhosis
2014 Floreani, Annarosa; Franceschet, I.; Perini, L.; Cazzagon, N.; Gershwin, M. E.; Bowlus, C. L.
Incidence and risk factors for extra-hepatic malignancies in primary biliary cirrhosis: A comparative study from two European referral centers
2014 Cazzagon, N.; Pares, A.; Spinazze', Alice; Caballeria, L.; Reig, A.; Franceschet, I.; Baldo, V.; Buja, A.; Furlan, P.; Floreani, A.